Madrigal Pharmaceuticals Inc (MDGL)
193.33
-1.05
(-0.54%)
USD |
NASDAQ |
Apr 26, 16:00
192.00
-1.33
(-0.69%)
Pre-Market: 20:00
Madrigal Pharmaceuticals Price to Book Value: 9.490 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 9.490 |
April 25, 2024 | 9.542 |
April 24, 2024 | 10.05 |
April 23, 2024 | 10.72 |
April 22, 2024 | 10.48 |
April 19, 2024 | 10.41 |
April 18, 2024 | 10.91 |
April 17, 2024 | 11.21 |
April 16, 2024 | 11.44 |
April 15, 2024 | 11.36 |
April 12, 2024 | 11.61 |
April 11, 2024 | 12.04 |
April 10, 2024 | 12.01 |
April 09, 2024 | 12.24 |
April 08, 2024 | 12.21 |
April 05, 2024 | 11.93 |
April 04, 2024 | 11.85 |
April 03, 2024 | 12.04 |
April 02, 2024 | 12.00 |
April 01, 2024 | 12.55 |
March 28, 2024 | 13.11 |
March 27, 2024 | 12.70 |
March 26, 2024 | 12.16 |
March 25, 2024 | 12.16 |
March 22, 2024 | 12.18 |
Date | Value |
---|---|
March 21, 2024 | 12.53 |
March 20, 2024 | 12.71 |
March 19, 2024 | 13.04 |
March 18, 2024 | 13.90 |
March 15, 2024 | 13.27 |
March 14, 2024 | 11.96 |
March 13, 2024 | 13.40 |
March 12, 2024 | 12.89 |
March 11, 2024 | 12.77 |
March 08, 2024 | 12.53 |
March 07, 2024 | 12.32 |
March 06, 2024 | 12.63 |
March 05, 2024 | 12.20 |
March 04, 2024 | 12.10 |
March 01, 2024 | 12.35 |
February 29, 2024 | 11.59 |
February 28, 2024 | 12.48 |
February 27, 2024 | 11.77 |
February 26, 2024 | 11.42 |
February 23, 2024 | 11.61 |
February 22, 2024 | 12.20 |
February 21, 2024 | 11.19 |
February 20, 2024 | 11.26 |
February 16, 2024 | 11.43 |
February 15, 2024 | 10.90 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.407
Minimum
Apr 03 2020
495.87
Maximum
Dec 29 2022
25.32
Average
7.466
Median
Jan 11 2021
Price to Book Value Benchmarks
Eli Lilly and Co | 64.74 |
Viking Therapeutics Inc | 8.774 |
Akero Therapeutics Inc | 2.542 |
89bio Inc | 1.467 |
Geron Corp | 8.347 |
Price to Book Value Related Metrics
PS Ratio | 548.38 |
Price | 193.33 |
Earnings Yield | -10.33% |
Market Cap | 3.847B |